在心力衰竭中血清氧化水平与保存的喷射部分:一个前性的病例控制研究
Musa Dagli1, Murat Kerkütlüoğlu2, Filiz Alkan Baylan3
1Cardiology, Akşehir Devlet Hastanesi, Konya, TUR.
Cureus
|October 24, 2025
概括
在心力衰竭患者中,血清中氧化的水平显著更高,心力衰竭患者具有保存的喷射分数 (HFpEF). 这些发现表明,氧醇可能是HFpEF的新生物标志物,反映了疾病机制.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 生物标志物发现发现
背景情况:
- 保持喷射分数 (HFpEF) 的心力衰竭是一个日益增长的临床挑战,治疗选择有限.
- 氧化醇,胆固醇氧化产物,与心血管疾病有关,但它们在HFpEF中的作用尚不清楚.
研究的目的:
- 调查血清中氧化醇水平与HFpEF之间的关联.
- 探索氧醇作为HFpEF的潜在新生物标志物.
主要方法:
- 101名参与者的前性研究 (51名HFpEF患者,50名对照).
- 血清氧化胆固醇 (7-基托胆固醇,25-氧胆固醇,7α,25-二氧胆固醇) 用LC/MS测量.
- 与临床,生化 (NT-proBNP) 和心声回声数据分析的相关性.
主要成果:
- 与对照组相比,HFpEF患者显示所有测量的氧化的血清水平显著更高 (p < 0.001).
- 氧化胆固醇水平与NT-proBNP有很强的相关性 (r=0.630-0.778,p < 0.001).
- 观察到与BMI和左心脏直径的弱相关性;与并发症无关.
结论:
- 这项研究首次表明,HFpEF患者的血清氧化水平升高.
- 氧醇与NT-proBNP相关,表明它们可能是HFpEF生物标志物.
- 需要进一步的多中心研究来确认发现和预后价值.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
550
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
550
Heart Failure II: Pathophysiology
707
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707
Heart Failure III: Clinical Manifestations
473
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
473
Acute Coronary Syndrome III: Diagnostic Studies
209
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
209
Coronary Artery Disease III: Clinical Manifestations
322
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
322
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
535
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
535


